poLight (PLT) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue declined to NOK 1.9 million from NOK 3.1 million year-over-year, reflecting slow sales but ongoing development in AR/MR, barcode, and healthcare segments.

• The company expanded its pipeline with new purchase orders in barcode and machine vision, and commercial launches in healthcare imaging.

• Patent infringement lawsuits were filed against two TLens® customers, with management asserting no infringement.

• Manufacturing focused on industrial and healthcare deliveries, with yield improvements and organizational expansion in the Philippines.

• The organization grew to nearly 50 employees, with a focus on building capabilities in key global markets.

Financial highlights

• Q3 2024 revenue was NOK 1.9 million, down from NOK 3.1 million in Q3 2023.

• EBITDA loss widened to NOK 25.2 million from NOK 20.5 million year-over-year.

• Cash and cash equivalents at period-end were NOK 180.1 million, supported by a NOK 124 million rights issue in Q2 2024.

• Net cash outflow from operations in Q3 2024 was NOK 19.0 million.

• Inventory provision for obsolescence increased to NOK 20.3 million.

Outlook and guidance

• Management remains optimistic about future growth, citing strong positioning in AR/MR, barcode, and healthcare markets.

• Ongoing technology programs and manufacturing optimization are expected to support long-term business potential.

• AR/MR market is expected to become significant around 2026–2027, though timing remains uncertain.

• No short-term design wins are expected in AR/MR, but long-term prospects are strong.

• The company is yet to explore several market segments with significant business opportunities.